Islet Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Islet Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating vatalanib in combination with octreotide for progressive neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [Phase 2]
A Phase 2 clinical trial of antineoplaston therapy for Merkel cell carcinoma, islet cell carcinoma, neuroendocrine carcinoma, and pituitary …